Oncobiologics, Inc.
Oncobiologics, Inc. (ONS) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 44 transactions totaling $592.9K, demonstrating a bearish sentiment with -$592.9K in net insider flow. The most recent transaction on Nov 7, 2018 involved a transaction of 8,577,248 shares valued at $8.0M.
ONS Insider Activity Summary
Who Is Buying ONS Stock?
No significant insider buying has been recorded for ONS in the recent period.
Who Is Selling ONS Stock?
No significant insider selling has been recorded for ONS in the recent period.
Is Oncobiologics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ONS is bearish with an Insider Alignment Score of 0/100 and a net flow of -$592.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ONS Frequently Asked Questions
Understanding ONS Insider Activity
Insider trading at Oncobiologics, Inc. (ONS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ONS stock, having executed 44 transactions in the past 90 days. The most active insider is Ghiath M. Sukhtian (Executive), who has made 3 transactions totaling $12.5M.
Related Tools
Track Oncobiologics, Inc. Insider Activity
Get notified when executives and directors at ONS file new Form 4 transactions